Mind + Muscle

technical minds + legal muscle

Bracket
Sterne Kessler Goldstein Fox
Adam LaRock

Mind + Muscle

Adam LaRock

Associate

 
  • Adam LaRock
  • p 202.772.8794
  • f 202.371.2540
  • alarock@skgf.com

  • v-card

Adam LaRock is an associate in the Litigation Group. Adam concentrates his practice on complex patent litigation, with a special emphasis on pharmaceutical patent litigation under the Hatch-Waxman Act. He has worked on cases involving pharmaceuticals (new drug compounds, enantiomers, prodrugs, salt forms, solid state forms, combinations, formulations, methods of treatment), electromechanical apparatuses, diagnostic gene testing, and near-field communication devices. Adam has experience in all phases of litigation—pre-suit investigation, injunction practice, fact and expert discovery, claim construction, and dispositive-motion practice. Adam has also served as an integral member of multiple trial teams and has experience preparing and examining trial witnesses.

In addition to his work in the U.S. District Courts, Adam has experience in contested proceedings before the Patent Trial and Appeal Board, as well as appeals before the Federal Circuit.

Adam graduated from the Franklin Pierce Law Center at University of New Hampshire School of Law. Adam served for two years as an Articles Editor for IDEA: The Intellectual Property Law Review. During law school, he also interned at the Merrimack County Superior Court as a law clerk for Hon. Carol Ann Conboy and at the New Hampshire Attorney General’s Office. Before joining Sterne Kessler, Adam practiced as a patent litigator in New York City, with particular emphasis on Hatch-Waxman cases.

  • Represented generic pharmaceutical company in Hatch-Waxman case concerning platelet-aggregation inhibitor.
  • Represented generic pharmaceutical company in Hatch-Waxman case concerning laxative formulation.
  • Represented brand pharmaceutical company in multiple Hatch-Waxman cases and IPR proceeding concerning combination allergy drug.
  • Represented electronics company in an appeal from IPR proceeding concerning near-field communication devices.
  • Represented generic pharmaceutical company in Hatch-Waxman case concerning an enzyme inhibitor used to treat COPD.
  • Represented generic pharmaceutical company in Hatch-Waxman case concerning leading proton-pump inhibitor.
  • Represented generic pharmaceutical company in Hatch-Waxman case concerning leading antipsychotic drug.
  • Represented utility services company in district-court litigation concerning stray-voltage-detection-apparatus patents and also in an appeal from IPR proceeding.
  • Represented biotechnology company in district court litigation concerning diagnostic gene testing patents.
  • Represented generic pharmaceutical company in Hatch-Waxman case concerning antibacterial drug.
  • Represented brand pharmaceutical company and university in multiple Hatch-Waxman cases concerning nucleoside analog reverse transcriptase inhibitor used to treat HIV infection.
  • Representative Matters
      • Represented generic pharmaceutical company in Hatch-Waxman case concerning platelet-aggregation inhibitor.
      • Represented generic pharmaceutical company in Hatch-Waxman case concerning laxative formulation.
      • Represented brand pharmaceutical company in multiple Hatch-Waxman cases and IPR proceeding concerning combination allergy drug.
      • Represented electronics company in an appeal from IPR proceeding concerning near-field communication devices.
      • Represented generic pharmaceutical company in Hatch-Waxman case concerning an enzyme inhibitor used to treat COPD.
      • Represented generic pharmaceutical company in Hatch-Waxman case concerning leading proton-pump inhibitor.
      • Represented generic pharmaceutical company in Hatch-Waxman case concerning leading antipsychotic drug.
      • Represented utility services company in district-court litigation concerning stray-voltage-detection-apparatus patents and also in an appeal from IPR proceeding.
      • Represented biotechnology company in district court litigation concerning diagnostic gene testing patents.
      • Represented generic pharmaceutical company in Hatch-Waxman case concerning antibacterial drug.
      • Represented brand pharmaceutical company and university in multiple Hatch-Waxman cases concerning nucleoside analog reverse transcriptase inhibitor used to treat HIV infection.
  • Admissions
      • Court of Appeals for the Federal Circuit

      • District of Columbia

      • New York

      • United States Patent and Trademark Office

  • Education
    • J.D., Franklin Pierce Law Center, University of New Hampshire School of Law

    • B.S. Chemistry, Clarkson University with Great Distinction

    X

    Unsolicited e-mails and information sent to Sterne, Kessler, Goldstein & Fox P.L.L.C. will not be considered confidential or privileged, may be disclosed to others, may not receive a response, and do not create an attorney-client relationship with Sterne Kessler.  If you are not already a client of Sterne Kessler, do not include any confidential information in this message.